Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update

Go back to Catalyst Pharmaceuticals Announces First Quarter 2020 Financial Results and Provides Corporate Update

Catalyst Pharmaceuticals (CPRX) Tops Q1 EPS by 1c

May 11, 2020 5:00 PM EDT

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q1 EPS of $0.10, $0.01 better than the analyst estimate of $0.09. Revenue for the quarter came in at $29.1 million versus the consensus estimate of $31.46 million.

I am very proud of the way that the entire Catalyst team has quickly responded and... More